Given that benign proliferating diseases generally have lower proliferation rate than invasive cancers, this raises the suspicion that 99mTc-(V)DMSA reflects an earlier cell activation status of phosphorylated FAK in the process of increasing the rate of cell proliferation [5,6,8]. The gene discussed is PTK2; the disease is cancer.